Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage

American Journal of Physiology - Endocrinology and Metabolism

Volumn 301, Issue 5, 2011, Pages

  Miegueu, Pierre ^a   Cianflone, Katherine ^a   Richard, Denis ^a   St Pierre, David H ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Gastrointestinal hormones; Gene expression; Peroxisome proliferator activated receptor

Indexed keywords

ADIPONECTIN; CAVEOLIN 3; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID; FATTY ACID BINDING PROTEIN 4; G PROTEIN COUPLED RECEPTOR; GHRELIN RECEPTOR; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROL; MESSENGER RNA; MOTILIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THYMIDINE; WORTMANNIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FATTY ACID TRANSPORT; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MACRONUTRIENT; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIENT UPTAKE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RAT; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENERGY METABOLISM; GENE EXPRESSION; HUMANS; LIPID METABOLISM; MALE; MICE; MOTILIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80054928939     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00089.2011     Document Type: Article

References (50)

1. Asakawa A, Inui A, Momose K, Ueno N, Fujino MA, Kasuga M. Motilin increases food intake in mice. Peptides 19: 987-990, 1998.
2. Bassil AK, Dass NB, Murray CD, Muir A, Sanger GJ. Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon. Eur J Pharmacol 524: 138-144, 2005.
3. Bjornsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol 29: 1096-1104, 1994.
4. Boney CM, Gruppuso PA, Faris RA, Frackelton AR Jr. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. Mol Endocrinol 14: 805-813, 2000.
5. Brown JC, Mutt V, Dryburgh JR. The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol 49: 399-405, 1971.
6. Christofides ND, Long RG, Fitzpatrick ML, McGregor GP, Bloom SR. Effect of motilin on the gastric emptying of glucose and fat in humans. Gastroenterology 80: 456-460, 1981.
7. Civalleri D, Bloom SR, Sarson DL, Gianetta E, Bonalumi U, Friedman D, Pitton L, Brignole E, Binda PL, Degrandi R, Scopinaro N. [Behavior of plasma pancreatic polypeptides and motilin in obese patients subjected to biliopancreatic bypass]. Boll Soc Ital Biol Sper 56: 1929-1935, 1980.
8. Cui W, Lapointe M, Gauvreau D, Kalant D, Cianflone K. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation. Mol Immunol 46: 3207-3217, 2009.
9. Cuomo R, Vandaele P, Coulie B, Peeters T, Depoortere I, Janssens J, Tack J. Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways. Am J Gastroenterol 101: 804-811, 2006.
10. Dass NB, Hill J, Muir A, Testa T, Wise A, Sanger GJ. The rabbit motilin receptor: molecular characterisation and pharmacology. Br J Pharmacol 140: 948-954, 2003.
11. El-Salhy M. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 35: 194-198, 1998.
12. Fiorucci S, Scionti L, Bosso R, Desando A, Bottini P, Marino C, Morelli A. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 37: 1671-1677, 1992.
13. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. Cell 5: 19-27, 1975.
14. Hanson M, Almer LO, Ekman R, Janzon L, Trell E. Motilin response to a glucose load aberrant in smokers. Scand J Gastroenterol 22: 809-812, 1987.
15. He J, Irwin DM, Chen R, Zhang YP. Stepwise loss of motilin and its specific receptor genes in rodents. J Mol Endocrinol 44: 37-44, 2010.
16. Imura H, Seino Y, Mori K, Itoh Z, Yanaihara N. Plasma motilin levels in normal subjects and patients with diabetes mellitus and certain other diseases. Fasting levels and responses to food and glucose. Endocrinol Jpn 27 Suppl 1: 151-155, 1980.
17. Itoh Z. Motilin and clinical application. Peptides 18: 593-608, 1997.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
19. Lahnalampi M, Heinaniemi M, Sinkkonen L, Wabitsch M, Carlberg C. Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis. PLoS One 5: e12991, 2010.
20. Liu H, Qiu D, Zhou X, Niu W, Qin X, Cai Y, Wang J, Chen Y. Erythromycin inhibited glycinergic inputs to gastric vagal motoneurons in brainstem slices of newborn rats. Neurogastroenterol Motil 22: 1232-1239, 2010.
21. Liu M, Dong L, Zhu WY. [Distribution and role of motilin receptor in the amygdala of rats]. Di Yi Jun Yi Da Xue Xue Bao 25: 1100-1104, 2005.
22. MacLaren R, Cui W, Simard S, Cianflone K. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res 49: 308-323, 2008.
23. MacLaren RE, Cui W, Lu H, Simard S, Cianflone K. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics 3: 3, 2010.
24. Majumdar ID, Weber HC. Gastrointestinal regulatory peptides and their effects on fat tissue. Curr Opin Endocrinol Diabetes Obes 17: 51-56, 2010.
25. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46: 426-434, 1997.
26. Miegueu P, St-Pierre DH, Broglio F, Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 112: 704-714, 2011.
27. Momose K, Inui A, Asakawa A, Ueno N, Nakajima M, Kasuga M. Anxiolytic effect of motilin and reversal with GM-109, a motilin antagonist, in mice. Peptides 19: 1739-1742, 1998.
28. Nakanome C, Akai H, Hongo M, Imai N, Toyota T, Goto Y, Okuguchi F, Komatsu K. Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus. Tohoku J Exp Med 139: 205-215, 1983.
29. Nilsson H, Bergstrom B, Lilja B, Juul-Moller S, Carlsson J, Sundkvist G. Prospective study of autonomic nerve function in type 1 and type 2 diabetic patients: 24 hour heart rate variation and plasma motilin levels disturbed in parasympathetic neuropathy. Diabet Med 12: 1015-1021, 1995.
30. Pieramico O, Malfertheiner P, Nelson DK, Glasbrenner B, Ditschuneit H. Interdigestive gastroduodenal motility and cycling of putative regulatory hormones in severe obesity. Scand J Gastroenterol 27: 538-544, 1992.
31. Poitras P, Miller P, Gagnon D,. and St-Pierre S. Motilin synthetic analogues and motilin receptor antagonists Biochem Biophys Res Commun 205: 449-454, 1994.
32. Poitras P, Peeters Motilin TL. Curr Opin Endocrinol Diabetes Obes 15: 54-57, 2008.
33. Richter WO, Schwandt P. Glycerol release from incubated human adipocytes is not affected by gastrointestinal peptides. Int J Obes 9: 25-27, 1985.
34. Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 48: 20-27, 2001.
35. Soder O, Hellstrom PM. Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis. Int Arch Allergy Appl Immunol 84: 205-211, 1987.
36. Soulie ML, Cros G, Serrano JJ, Bali JP. Impairment of contractile response to carbachol and muscarinic receptor coupling in gastric antral smooth muscle cells isolated from diabetic streptozotocin-treated rats and db/db mice. Mol Cell Biochem 109: 185-188, 1992.
37. Sun Q, Zang WJ, Chen C. Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes. Endocrinology 151: 1228-1235, 2010.
38. Suzuki H, Kuwano H, Mochiki E, Haga N, Shimura T, Nomoto K, Tanaka T, Mizumoto A, Itoh Z. Effect of motilin on endogenous release of insulin in conscious dogs in the fed state. Dig Dis Sci 48: 2263-2270, 2003.
39. Suzuki H, Mochiki E, Haga N, Satoh M, Mizumoto A, Itoh Z. Motilin controls cyclic release of insulin through vagal cholinergic muscarinic pathways in fasted dogs. Am J Physiol Gastrointest Liver Physiol 274: G87-G95, 1998.
40. Takeshita E, Matsuura B, Dong M, Miller LJ, Matsui H, Onji M. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 41: 223-230, 2006.
41. Ter Beek WP, Muller ES, van den Berg M, Meijer MJ, Biemond I, Lamers CB. Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine. Inflamm Bowel Dis 14: 612-619, 2008.
42. Tesauro M, Schinzari F, Caramanti M, Lauro R, Cardillo C. Metabolic and cardiovascular effects of ghrelin. Int J Pept pii: 864342, 2010. Epub 2010 Mar 16. PMID: 20798901.
43. Ueno N, Inui A, Asakawa A, Takao F, Tani S, Komatsu Y, Itoh Z, Kasuga M. Erythromycin improves glycaemic control in patients with Type II diabetes mellitus. Diabetologia 43: 411-415, 2000.
44. van Assche G, Depoortere I, de Vos R, Geboes K, Janssens JJ, Collins SM, Peeters TL. Region-specific antiproliferative effect of VIP and PACAP-(1-38) on rabbit enteric smooth muscle. Am J Physiol Gastrointest Liver Physiol 276: G303-G310, 1999.
45. van Assche G, Depoortere I, Peeters TL. Localization of motilin binding sites in subcellular fractions from rabbit antral and colonic smooth muscle tissue. Regul Pept 77: 89-94, 1998.
46. Weiss H, Labeck B, Klocker J, Nehoda H, Mittermair R, Aigner F, Gadenstatter M, Schwelberger H, Wetscher G. Effects of adjustable gastric banding on altered gut neuropeptide levels in morbidly obese patients. Obes Surg 11: 735-739, 2001.
47. Wen Y, Wang H, MacLaren R, Wu J, Lu H, Cianflone K. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. J Cell Biochem 104: 391-401, 2008.
48. Wierup N, Bjorkqvist M, Westrom B, Pierzynowski S, Sundler F, Sjolund K. Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab 92: 3573-3581, 2007.
49. Yang X, Dong L, Yang H. [Evidence for the presence of motilin receptor and a study on the mechanism of motilin induced Ca2+ signaling in rat myenteric neurons]. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 683-686, 2006.
50. Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, Mulholland MW. Inhibition of adipogenesis by ghrelin. Mol Biol Cell 15: 2484-2491, 2004.